Devendra Kumar
Overview
Explore the profile of Devendra Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
889
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar D, Prabhakar S, Heidous M, Macdonald D, Venugopalan Nair A
Abdom Radiol (NY)
. 2025 Feb;
PMID: 39969608
Spontaneous abdominal hemorrhage (SAH) refers to acute intra-abdominal or pelvic hemorrhages occurring from non-traumatic or non-iatrogenic causes. Early recognition of SAH with prompt surgical or interventional management is necessary to...
2.
Kumar D, Kanchan R, Chaturvedi N
Discov Oncol
. 2025 Jan;
16(1):23.
PMID: 39779613
MYC is one of the most deregulated oncogenic transcription factors in human cancers. MYC amplification/or overexpression is most common in Group 3 medulloblastoma and is positively associated with poor prognosis....
3.
Rahman J, Kumar D, Singh S, Shahi B, Ghosh A, Dar A, et al.
Trop Anim Health Prod
. 2024 Dec;
57(1):10.
PMID: 39715884
Genome-wide association studies (GWAS) offer potential for discovering genomic regions that can be exploited to increase milk production. However, available GWAS and single nucleotide polymorphism (SNP) datasets are heavily skewed...
4.
Krishna S, Nema S, Sangle R, Ahmad A, Singh A, Kumar D, et al.
PLoS One
. 2024 Dec;
19(12):e0315662.
PMID: 39693284
Rapid diagnostic tests (RDTs) are crucial for diagnosing malaria in resource-limited settings. These tests, which detect the histidine-rich protein 2 (PfHRP2) and its structural homologue PfHRP3, are specifically designed to...
5.
Raval H, Bhattacharya S, Bhirud D, Sangave P, Gupta G, Paraskar G, et al.
J Control Release
. 2024 Dec;
377:810-841.
PMID: 39637989
This study presents the development of melatonin-coated lactoferrin-chitosan nanoparticles (ETP-CS-LF-MLT-NPs) using ionic gelation and carbodiimide coupling for colorectal cancer treatment. The nanoparticles were characterized by an average size of 208.7 ...
6.
Sathe B, Jaiswal S, Kumar D, Singh T, Nainwal N, Rawat P, et al.
Chem Biol Drug Des
. 2024 Dec;
104(6):e70023.
PMID: 39635932
Mer-tyrosine kinase (MERTK), a member of the AXL, TYRO3, and MERTK (TAM) family, is one of the promising targets for cancer treatment. It plays a key role in cancer cell...
7.
Vaibhav K, Sahu A, Prasad R, Deb D, Kumar D, Karimi A
Asian J Neurosurg
. 2024 Nov;
19(4):707-714.
PMID: 39606312
Chronic subdural hematoma (CSDH) is a common neurological problem with significant recurrence after surgery. Risk considerations can vary, ranging from patient-related factors to those related to the surgical procedure. This...
8.
Thakur S, Kumar D, Jaiswal S, Goel K, Rawat P, Srivastava V, et al.
RSC Med Chem
. 2024 Nov;
PMID: 39601022
Thiophene is a privileged pharmacophore in medicinal chemistry owing to its diversified biological attributes. The thiophene moiety has been ranked 4th in the US FDA drug approval of small drug...
9.
Bhirud D, Bhattacharya S, Raval H, Sangave P, Gupta G, Paraskar G, et al.
Carbohydr Polym
. 2024 Nov;
348(Pt B):122935.
PMID: 39567152
The study aimed to develop and evaluate chitosan-based nanoparticles coated with TPGS for the targeted delivery of imatinib mesylate to colon cancer cells. Particle size and zeta potential analysis were...
10.
Kamble S, Kamble C, Gawai U, Kumar D, Chavan P, Gurav S
RSC Adv
. 2024 Nov;
14(49):36667-36674.
PMID: 39559571
Nanocomposites of 20% and 30% Co-doped Ni/NiO were synthesized using a microwave-assisted sol-gel auto-combustion method. The 30% Co-doped Ni/NiO nanocomposite exhibited negative magnetoresistance (M-R) at various temperatures, including 2 K,...